Innovative Medicines Initiative

Company

Investment-firm

Financing round

General

About Company
Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development

Industry

Sector :

Subsector :

Also Known As

IMI, IMI2

founded date

01.01.2008

Number of employees

Company Type

For Profit

IPO status

Private

Description

IMI is Europe's largest public-private initiative that aims to improve health by promoting collaboration between universities, pharmaceutical industries, SMEs, patient organizations, and regulators. The company invests in pharmaceutical and biotechnology sectors to address medical or social needs where there is an unmet demand. Founded in 2008, IMI is based in Brussels, Belgium, and is a partnership between the European Union and the European pharmaceutical industry represented by EFPIA.
Contacts
Similar Companies
999
IFPMA

IFPMA

IFPMA is a global organization advocating for the discovery and accessibility of life-saving medicines and vaccines worldwide.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Pharmaceuticals, Health Care, Non-Profit

Location

Geneva, Switzerland
PhRMA (Pharmaceutical Researcher and Manufacturers of America)

PhRMA (Pharmaceutical Researcher and Manufacturers of America)

PhRMA advocates for policies that support pharmaceutical research and patient access to medicines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Manufacturing, Pharmaceuticals, Biotechnology

Location

Washington Cir NW, Washington, DC, USA
Teva Pharmaceutical Industries

Teva Pharmaceutical Industries

Teva Pharmaceuticals is a global biotechnology company that develops and produces medicines to improve people's lives.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Petah Tikva, Israel

total rounds

3

total raised

$2.71B

count Of Investments

10

count Of Exists

5
Association Innovative Medicines

Association Innovative Medicines

The Vereniging Innovatieve Geneesmiddelen represents pharmaceutical companies developing innovative medicines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Financials

Investments
2
Date 
name 
Lead 
type 
Raised 
15.05.2020
Yes
$3.9M
Local Amount - EUR 3.6M
01.01.2019
Yes
Exvastat

Exvastat

Exvastat is a preclinical-stage pharmaceutical company that develops drugs to cure acute respiratory distress syndrome.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, UK

total rounds

2

total raised

$3.9M
MetaHeps

MetaHeps

MetaHeps is a unique service provider that offers personalized cell models for drug-induced liver injury (DILI) using patient blood samples.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Pharmaceuticals

Location

Martinsried, 82152 Planegg, Germany

total rounds

4
Co-Investors

People

Employee Profiles
2
Kyle Rose

Kyle Rose

INNODIA PAC Steering Committee Member

Pierre Meulien

Pierre Meulien

Director

Activity

Recent News
0